|
2024
|
P/S
|
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular d... |
|
|
Invention
|
Adeno-associated virus vectors for treatment of rett syndrome.
The disclosure provides nucleic a... |
|
|
Invention
|
Fusion proteins comprising cas enzymes and dna-binding proteins. Disclosed herein are fusion prot... |
|
|
Invention
|
Antisense oligomers for treatment of chronic kidney disease. Provided herein are compounds such a... |
|
|
Invention
|
Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment... |
|
|
Invention
|
Raav production methods. Disclosed herein are improved methods of production of recombinant adeno... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
neuromuscular diseases and disorders, muscular ... |
|
|
Invention
|
Antisense-induced exon exclusion in type vii collagen.
The present disclosure relates to antisen... |
|
2023
|
Invention
|
Formulation of an antisense oligomer conjugate.
Provided herein are pharmaceutical compositions ... |
|
|
Invention
|
Formulation of an antisense oligomer conjugate. Provided herein are pharmaceutical compositions c... |
|
|
Invention
|
Exon skipping oligomers for muscular dystrophy.
Antisense oligomers complementary to a selected ... |
|
|
Invention
|
Pompe disease mouse model generation, characterization and methods of use. Disclosed herein are t... |
|
|
Invention
|
Recombinant aav vectors for treating muscular dystrophy. DMDDMD gene to determine if rAAV gene th... |
|
|
Invention
|
Dmd antisense oligonucleotide-mediated exon skipping efficiency. Provided herein are oligonucleot... |
|
|
Invention
|
Methods of treating muscular dystrophy. e.ge.g., an AAVrh74 vector, and an enzyme that cleaves Ig... |
|
|
P/S
|
Connecting healthcare providers with medical specialists and researchers to enable communication ... |
|
|
Invention
|
Oligonucleotides for treating expanded repeat diseases.
The invention provides for a method for ... |
|
|
Invention
|
Peptide oligonucleotide conjugates.
Provided herein are oligonucleotides, peptides, and peptide-... |
|
|
Invention
|
Phosphorodiamidate morpholino oligomer conjugates. Novel antisense oligonucleotide conjugates tha... |
|
|
Invention
|
Exon skipping oligomer conjugates for muscular dystrophy.
Antisense oligomer conjugates compleme... |
|
2022
|
Invention
|
Antisense oligomer compounds.
A modified antisense oligonucleotide of about 10 to about 40 nucle... |
|
|
Invention
|
Exon skipping oligomer conjugates for muscular dystrophy.
Antisense oligomers complementary to a... |
|
|
Invention
|
Morpholino oligomers for treatment of peripheral myelin protein 22 related diseases.
Provided he... |
|
|
Invention
|
Morpholino oligomers for treatment of peripheral myelin protein 22 related diseases. Provided her... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of muscular dystrophies, central nervous system dis... |
|
|
Invention
|
Antisense oligonucleotides having one or more abasic units.
Provided herein are oligonucleotides... |
|
|
Invention
|
Antisense oligonucleotides having one or more abasic units. Provided herein are oligonucleotides,... |
|
|
Invention
|
Delivery of anitsense oligomers by mirror image peptides.
Provided herein are oligonucleotides, ... |
|
|
Invention
|
Delivery of anitsense oligomers by mirror image peptides. Provided herein are oligonucleotides, c... |
|
|
P/S
|
Pharmaceutical preparations. Medical education services; Medical training and teaching. Medical s... |
|
|
Invention
|
Processes for preparing phosphorodiamidate morpholino oligomers.
Provided herein are processes f... |
|
|
Invention
|
Production of recombinant aav vectors for treating muscular dystrophy.
The present disclosure pr... |
|
|
Invention
|
Production of recombinant aav vectors for treating muscular dystrophy. The present disclosure pro... |
|
|
Invention
|
Exon skipping compositions for treating muscular dystrophy.
Antisense molecules capable of bindi... |
|
|
Invention
|
Exon skipping oligomer conjugates for muscular dystrophy. Antisense oligomer conjugates complemen... |
|
|
Invention
|
Treatment methods for muscular dystrophy.
New dosing regimens for treating muscular dystrophy in... |
|
|
Invention
|
Treatment methods for muscular dystrophy. New dosing regimens for treating muscular dystrophy in ... |
|
|
P/S
|
Providing health information; Providing health information in the field of muscular dystrophy, Du... |
|
|
Invention
|
Compositions for treating muscular dystrophy.
Improved compositions and methods for treating mus... |
|
2021
|
Invention
|
Compositions comprising exon skipping oligonucleotide conjugates for treating muscular dystrophy.... |
|
|
Invention
|
Suspension mode seed train development for adherent cells.
The disclosure is directed to a metho... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders |
|
|
P/S
|
Providing health information |
|
|
P/S
|
Pharmaceutical preparations featuring antisense oligonucleotides for the treatment of neuromuscul... |
|
|
Invention
|
Antisense oligomers and methods of using the same for treating diseases associated with the acid ... |
|
|
P/S
|
Providing information about medical and healthcare research and clinical trials; providing inform... |
|
|
P/S
|
Pharmaceutical preparations featuring antisense oligonucleotides, for the treatment of neuromuscu... |
|
2020
|
Invention
|
Methods for analyzing aav capsid proteins.
Provided are methods to characterize the VP1, VP2 and... |
|
|
Invention
|
Compositions and methods for restoring and maintaining the dystrophin-associated protein complex ... |
|
|
Invention
|
Aav transfer cassette.
Described herein are AAV transfer cassettes and plasmids used in the prod... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders. |
|
|
P/S
|
Medical and scientific research services, namely, medical
research; medical and scientific resea... |
|
|
Invention
|
Methods for treating muscular dystrophy.
Methods for treating muscular dystrophy by administerin... |
|
2018
|
Invention
|
Methods for treating muscular dystrophy.
The present disclosure provides, among other things, im... |
